Celltrion Healthcare Co., Ltd. Celltrion Healthcare Co., Ltd.

Celltrion Healthcare Co., Ltd.

091990

Rang in aandelen #2142
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
Aandeelprijs
$57.75
Laatst gesynchroniseerd: 2024-01-11
Marktkapitalisatie
$9.42B
Verandering (1 dag)
-0.25%
Verandering (1 jaar)
0.00%
Land
KR
Handel Celltrion Healthcare Co., Ltd. (091990)

Categorie

Healthcare
Aandelsplitsingen voor Celltrion Healthcare Co., Ltd. (091990)
Het aandeel Celltrion Healthcare Co., Ltd. (symbool: 091990) heeft in totaal 6 splitsingen ondergaan.
De meest recente splitsing vond plaats op Dec 28, 2022.
Eén aandeel 091990 dat vóór Dec 27, 2017 werd gekocht, staat nu gelijk aan 0.75210180542056 aandelen 091990.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2022-12-28 26:25 x1.04 x0.75210180542056
2021-12-29 51:52 x0.98076923076923 x0.72317481290438
2020-12-29 25:26 x0.96153846153846 x0.73735471119663
2019-12-27 21875:22542 x0.97041078874989 x0.76684889964449
2018-12-27 1020000:1136117 x0.89779485739585 x0.79023121809308
2017-12-27 60000:68167 x0.88019129490809 x0.88019129490809
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 1 x100
BE